These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18556970)

  • 21. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.
    Khwaja OS; Ho E; Barnes KV; O'Leary HM; Pereira LM; Finkelstein Y; Nelson CA; Vogel-Farley V; DeGregorio G; Holm IA; Khatwa U; Kapur K; Alexander ME; Finnegan DM; Cantwell NG; Walco AC; Rappaport L; Gregas M; Fichorova RN; Shannon MW; Sur M; Kaufmann WE
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4596-601. PubMed ID: 24623853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans.
    Backeljauw PF; Chernausek SD
    Horm Res; 2006; 65 Suppl 1():21-7. PubMed ID: 16508330
    [No Abstract]   [Full Text] [Related]  

  • 25. Mecasermin rinfabate.
    Kemp SF
    Drugs Today (Barc); 2007 Mar; 43(3):149-55. PubMed ID: 17380212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
    Clark RG
    Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency.
    Lordereau-Richard I; Roger M; Chaussain JL
    Acta Paediatr Suppl; 1994 Apr; 399():152. PubMed ID: 7949605
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment with Recombinant Human Insulin-Like Growth Factor-1 in Severe Primary IGF Deficiency and Beyond.
    Ranke MB
    Horm Res Paediatr; 2015; 83(5):358-60. PubMed ID: 25871890
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency.
    Thorén MC; Wivall-Helleryd IL; Blum WF; Hall KE
    Eur J Endocrinol; 1994 Jul; 131(1):33-40. PubMed ID: 7518727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity).
    Sivan B; Lilos P; Laron Z
    J Pediatr Endocrinol Metab; 2003; 16(4):509-20. PubMed ID: 12793602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
    Backeljauw PF; Underwood LE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The insulin-like growth factors and growth disorders of childhood.
    Backeljauw PF; Chernausek SD
    Endocrinol Metab Clin North Am; 2012 Jun; 41(2):265-82, v. PubMed ID: 22682630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
    Rosenbloom AL
    J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic potential of recombinant human insulin-like growth factor-I.
    Cotterill AM
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):11-5. PubMed ID: 1424187
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.